Institute of Pharmacy, Department of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), Ernst Moritz Arndt University Greifswald, Felix-Hausdorff-Straße 3, D-17487 Greifswald, Germany.
Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Ferdinand-Sauerbruch-Straße, D-17475 Greifswald, Germany.
J Control Release. 2016 Apr 10;227:1-12. doi: 10.1016/j.jconrel.2016.02.029. Epub 2016 Feb 17.
The present pilot study introduces a method that might give novel insights in drug absorption processes from intramuscularly administered depots. An oily suspension or an aqueous solution of paracetamol (6 mg/kg body mass), prednisolone or its hemisuccinate sodium salt for the aqueous solutions (10mg/kg body mass) or diclofenac (10mg/kg body mass) was injected into the muscle tissue of the hind leg of female Lewis-rats (n=47). For the oily suspensions the micronized particles were suspended in medium-chain triglycerides. The aqueous solutions were buffered to a pH of 7.4 ± 0.5. Polyethylene glycol was added as a cosolvent in the formulations containing paracetamol (acetaminophen) and diclofenac and sodium chloride was added to the aqueous solutions of prednisolone hemisuccinate sodium to achieve nearly isotonic formulations. The formed depot was visualized by magnetic resonance imaging (MRI) and characterized with regard to volume and surface area. A 7 T-small animal scanner was used and T1-weighted and T2-weighted sequences including a fat saturation were performed. Simultaneously blood samples were taken and the drugs were quantitatively analyzed. The water based solvent and the oily dispersion agent were visible in the MRI images without the use of contrast agents. Since a free hand injection mostly led to an application directly into the fascia, resulting in a fast removal of the depot, MRI-guided injection was conducted. Comparing pharmacokinetic data with MRI data it was observed that maximal blood levels occurred before the solvent and the dispersion agent were removed from the muscle tissue. Thus, the drug is not absorbed together with the depot. Furthermore, no correlation was found between the shape of the depot and the rate of absorption. Consequently, a higher surface area or volume of the depot did not result in a faster release or absorption of the drugs from the tested formulations. In contrast to the paracetamol and prednisolone formulations the formulations containing diclofenac led to a massive accumulation of interstitial fluid around the injection area being a sign for an acute local reaction. Histological analysis of the muscle tissue revealed a clear correspondence between the amount of interstitial fluid and the extent of infiltrating lymphocytes and granulocytes indicating a tissue response. In conclusion combining MRI with pharmacokinetic data is a suitable method to gain deeper insights into drug absorption processes from intramuscular depots. Furthermore, MRI offers a great possibility detecting local side effects caused by an intramuscularly applied dosage form. This might be very useful in preclinical phases during the development of new intramuscular formulations.
本初步研究介绍了一种方法,可能为肌肉内给药的药物吸收过程提供新的见解。将对乙酰氨基酚(6 毫克/千克体重)、泼尼松龙或其琥珀酸半钠盐(水溶液,10 毫克/千克体重)或双氯芬酸钠(10 毫克/千克体重)的油性混悬液或水溶液注射到雌性 Lewis 大鼠后腿的肌肉组织中(n=47)。对于油性混悬液,将微粒化颗粒混悬于中链甘油三酯中。将水溶液缓冲至 pH 值 7.4±0.5。在含有对乙酰氨基酚和双氯芬酸钠的制剂中添加聚乙二醇作为共溶剂,并向泼尼松龙琥珀酸半钠盐的水溶液中添加氯化钠以达到等渗制剂。通过磁共振成像(MRI)可视化形成的储库,并对其体积和表面积进行特征描述。使用 7 T 小动物扫描仪进行 T1 加权和 T2 加权序列,包括脂肪饱和。同时采集血样并定量分析药物。无需使用造影剂即可在 MRI 图像中观察到水性溶剂和油性分散剂。由于自由手注射大多直接应用于筋膜,导致储库迅速被清除,因此进行了 MRI 引导注射。将药代动力学数据与 MRI 数据进行比较后发现,最大血药浓度出现在溶剂和分散剂从肌肉组织中清除之前。因此,药物不是与储库一起被吸收的。此外,储库的形状与吸收速率之间没有相关性。因此,对于从测试制剂中释放或吸收药物,较高的储库表面积或体积并不会导致更快的释放或吸收。与对乙酰氨基酚和泼尼松龙制剂不同,含有双氯芬酸钠的制剂会导致注射部位周围间质液大量积聚,这是急性局部反应的迹象。对肌肉组织的组织学分析显示,间质液的量与浸润的淋巴细胞和粒细胞的程度之间存在明显的对应关系,表明存在组织反应。总之,将 MRI 与药代动力学数据相结合是一种深入了解肌肉内储库药物吸收过程的合适方法。此外,MRI 提供了一种很好的可能性,可以检测到由肌肉内应用剂型引起的局部副作用。这在新的肌肉内制剂开发的临床前阶段可能非常有用。